Table Graph
      published meta-analysis   sensitivity analysis   studies

placebo in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias clinical improvement (time to event analysis only)detailed resultsShinkai, 2021 (REV) 0.71 [0.47; 1.10] 0.71[0.47; 1.10]Shinkai, 2021 (REV)10%156NAnot evaluable serious adverse eventsdetailed resultsShinkai, 2021 (REV) 0.36 [0.02; 7.27] 0.36[0.02; 7.27]Shinkai, 2021 (REV)10%156NAnot evaluable adverse eventsdetailed resultsShinkai, 2021 (REV) 0.05 [0.02; 0.13] 0.05[0.02; 0.13]Shinkai, 2021 (REV)10%156NAnot evaluable0.02.01.0relative treatment effectwww.metaEvidence.org2024-05-14 21:17 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 650 - roots T: 650

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons